Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease

I. Jialal, S. Devaraj

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies.

Original languageEnglish (US)
Pages (from-to)121-123
Number of pages3
JournalClinical Pharmacology and Therapeutics
Issue number2
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this